ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 78 filers reported holding ODONATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $115,000 | -61.8% | 85,538 | -17.3% | 0.00% | – |
Q3 2021 | $301,000 | -31.1% | 103,403 | -17.4% | 0.00% | – |
Q2 2021 | $437,000 | -66.5% | 125,138 | -67.2% | 0.00% | – |
Q1 2021 | $1,303,000 | -74.2% | 381,118 | +45.0% | 0.00% | – |
Q4 2020 | $5,048,000 | +51.1% | 262,916 | +5.7% | 0.00% | – |
Q3 2020 | $3,340,000 | -68.1% | 248,662 | +0.6% | 0.00% | -100.0% |
Q2 2020 | $10,466,000 | +72.7% | 247,181 | +12.6% | 0.00% | 0.0% |
Q1 2020 | $6,059,000 | -22.5% | 219,465 | -8.9% | 0.00% | 0.0% |
Q4 2019 | $7,815,000 | +45.7% | 240,818 | +16.8% | 0.00% | – |
Q3 2019 | $5,365,000 | +3.9% | 206,111 | +46.4% | 0.00% | – |
Q2 2019 | $5,165,000 | +113.6% | 140,767 | +28.7% | 0.00% | – |
Q1 2019 | $2,418,000 | +62.6% | 109,361 | +3.5% | 0.00% | – |
Q4 2018 | $1,487,000 | -34.1% | 105,634 | -9.2% | 0.00% | – |
Q3 2018 | $2,258,000 | +3.9% | 116,291 | +18.1% | 0.00% | – |
Q2 2018 | $2,173,000 | +12.8% | 98,490 | +8.3% | 0.00% | – |
Q1 2018 | $1,926,000 | – | 90,957 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $54,146,000 | 10.78% |
Boxer Capital, LLC | 5,607,086 | $19,569,000 | 0.69% |
Ikarian Capital, LLC | 1,986,412 | $6,933,000 | 0.56% |
Samsara BioCapital, LLC | 700,421 | $2,444,000 | 0.30% |
SILVERARC CAPITAL MANAGEMENT, LLC | 186,680 | $652,000 | 0.29% |
EcoR1 Capital, LLC | 831,200 | $2,901,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 113,360 | $396,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 230,794 | $805,000 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 41,210 | $144,000 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 81,180 | $283,000 | 0.02% |